Brief Description
Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.
Formerly known as Diassess, Inc.
Lucira Health had an initial public offering on the Nasdaq stock exchange under the ticker symbol of LHDX in 2021. In 2023, the company was acquired by Pfizer (NYS: PFE).
Timeline
- 2013. Company founded
- 2015. Joined Y-Combinator
- 2021. Initial public offering (NASDAQ: LHDX)
- 2023. Acquired by Pfizer (NYS: PFE)
Inventors
Ivan Dimov, Luke Lee, Jixiao Liu, Debkishore Mitra, Benjamin Ross, John Waldeisen